A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1

National Institute on Drug Abuse (NIDA)50 enrolled

Overview

The purpose of this study is to examine behavioral treatment for methamphetamine dependence.

To characterize meth. withdrawal symptoms using a multidimensional withdrawal questionnaire; to field test and investigate the effect of using an algorithm developed for discriminating between new use and residual carry-over of meth metabolites in urine and to evaluate the treatment response of meth. users to participation in the thrice weekly psychosocial protocol to be used as a "platform" in future pharmacotherapy trials.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Enrollment

Conditions

Substance-Related Disorders

Interventions

Behavior TherapyBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: Male or Female at least 18 yrs of age; DSM-4 diagnosis of methamphetamine (METH) dependence; be willing to comply with study procedures; verbalize understanding of consent and provide written consent and willingness to complete study procedures; be seeking treatment for METH dependence. Exclusion Criteria: Additional criteria available during screening at the site.

Locations (5)

South Bay Treatment Center

Chula Vista, California, United States

Matrix Institute on Addictions

Costa Mesa, California, United States

John A. Burns School of Medicine

Honolulu, Hawaii, United States

Powell Chemical Dependency Center

Des Moines, Iowa, United States

Outcomes

Primary Outcomes

Withdrawal symptoms

New Use algorithm

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.